TriSalus Life Sciences (TLSI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.63, -6.92% vs the prior close of $3.90.
- Volume 253.52K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TLSI slides 6.9% to $3.63, a 3-month low, 4 down days in a row. Closed at $3.63, -6.92% vs the prior close of $3.90. Day range $3.58–$3.90, opened at $3.90.
TLSI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TLSI slides 6.9% to $3.63, a 3-month low, 4 down days in a row
- Closed at $3.63, -6.92% vs the prior close of $3.90. Day range $3.58–$3.90, opened at $3.90.
- Volume was 253.52K shares, 0.9x its 50-day average of 293.01K.
- Price is -24.2% vs its 50-day average ($4.79) and -19.7% vs its 200-day average ($4.52).
- 52-week range $2.20–$7.95; today's close sits at 25% of that range, 54.3% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — TLSI ends flat (+0.0%) to $3.90, 3 down days in a row
- Closed at $3.90, +0.00% vs the prior close of $3.90. Day range $3.87–$4.01, opened at $3.94.
- Volume was 140.20K shares, 0.5x its 50-day average of 296.01K — lighter than usual.
- Price is -19.0% vs its 50-day average ($4.82) and -14.0% vs its 200-day average ($4.54).
- 52-week range $2.20–$7.95; today's close sits at 30% of that range, 50.9% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — TLSI dips 2.5% to $3.90, a 3-month low
- Closed at $3.90, -2.50% vs the prior close of $4.00. Day range $3.80–$4.01, opened at $3.91.
- Volume was 192.80K shares, 0.6x its 50-day average of 299.30K.
- Price is -19.3% vs its 50-day average ($4.83) and -14.3% vs its 200-day average ($4.55).
- 52-week range $2.20–$7.95; today's close sits at 30% of that range, 50.9% below the 52-week high.
Oct 13, 2026 — TLSI slides 3.4% to $4.00, a 3-month low
- Closed at $4.00, -3.38% vs the prior close of $4.14. Day range $3.94–$4.12, opened at $4.12.
- Volume was 120.10K shares, 0.4x its 50-day average of 299.60K — lighter than usual.
- Price is -17.5% vs its 50-day average ($4.85) and -12.4% vs its 200-day average ($4.57).
- 52-week range $2.20–$7.95; today's close sits at 31% of that range, 49.7% below the 52-week high.
Oct 12, 2026 — TLSI rises 2.0% to $4.14
- Closed at $4.14, +1.97% vs the prior close of $4.06. Day range $3.97–$4.15, opened at $4.10.
- Volume was 78.50K shares, 0.3x its 50-day average of 301.84K — lighter than usual.
- Price is -14.8% vs its 50-day average ($4.86) and -9.6% vs its 200-day average ($4.58).
- 52-week range $2.20–$7.95; today's close sits at 34% of that range, 47.9% below the 52-week high.
Oct 9, 2026 — TLSI dips 1.7% to $4.06, a 1-month low, 4 down days in a row
- Closed at $4.06, -1.69% vs the prior close of $4.13. Day range $3.93–$4.32, opened at $4.09.
- Volume was 198.90K shares, 0.7x its 50-day average of 300.13K.
- Price is -16.6% vs its 50-day average ($4.87) and -11.7% vs its 200-day average ($4.60).
- 52-week range $2.20–$7.95; today's close sits at 32% of that range, 48.9% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — TLSI dips 2.8% to $4.13, a 1-month low, 3 down days in a row
- Closed at $4.13, -2.82% vs the prior close of $4.25. Day range $4.02–$4.20, opened at $4.20.
- Volume was 275.50K shares, 0.9x its 50-day average of 297.35K.
- Price is -15.4% vs its 50-day average ($4.88) and -10.5% vs its 200-day average ($4.61).
- 52-week range $2.20–$7.95; today's close sits at 34% of that range, 48.1% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — TLSI dips 0.5% to $4.25
- Closed at $4.25, -0.47% vs the prior close of $4.27. Day range $4.09–$4.42, opened at $4.21.
- Volume was 185.30K shares, 0.6x its 50-day average of 296.40K.
- Price is -13.0% vs its 50-day average ($4.88) and -8.2% vs its 200-day average ($4.63).
- 52-week range $2.20–$7.95; today's close sits at 36% of that range, 46.5% below the 52-week high.
Oct 6, 2026 — TLSI dips 2.5% to $4.27
- Closed at $4.27, -2.51% vs the prior close of $4.38. Day range $4.25–$4.51, opened at $4.39.
- Volume was 153.10K shares, 0.5x its 50-day average of 295.22K — lighter than usual.
- Price is -12.6% vs its 50-day average ($4.89) and -8.1% vs its 200-day average ($4.64).
- 52-week range $2.20–$7.95; today's close sits at 36% of that range, 46.3% below the 52-week high.
Oct 5, 2026 — TLSI rises 1.4% to $4.38
- Closed at $4.38, +1.39% vs the prior close of $4.32. Day range $4.20–$4.40, opened at $4.30.
- Volume was 132.70K shares, 0.4x its 50-day average of 296.36K — lighter than usual.
- Price is -10.4% vs its 50-day average ($4.89) and -6.0% vs its 200-day average ($4.66).
- 52-week range $2.20–$7.95; today's close sits at 38% of that range, 44.9% below the 52-week high.
Oct 2, 2026 — TLSI jumps 4.1% to $4.32
- Closed at $4.32, +4.10% vs the prior close of $4.15. Day range $4.04–$4.47, opened at $4.22.
- Volume was 145.40K shares, 0.5x its 50-day average of 298.70K — lighter than usual.
- Price is -11.6% vs its 50-day average ($4.88) and -7.6% vs its 200-day average ($4.67).
- 52-week range $2.20–$7.95; today's close sits at 37% of that range, 45.7% below the 52-week high.
TLSI latest news & SEC filings
Every SEC filing by or about TLSI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cox Bryan F. sold 296 shares at $4.39 (≈$1.30K) on Oct 5, 2026; now holds 162,805
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Marshak Richard sold 325 shares at $4.39 (≈$1.43K) on Oct 5, 2026; now holds 127,994
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stevens Jennifer sold 316 shares at $4.39 (≈$1.39K) on Oct 5, 2026; now holds 123,794
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Szela Mary T had withheld for taxes 2,693 shares at $4.38 (≈$11.80K) on Oct 5, 2026; now holds 1,074,990
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $11.41M (prior year $11.21M) (+1.7% vs Jun 30, 2025)
- Net income: -$9.19M (prior year -$8.29M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.27) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TLSI
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 5, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.78% (largest 7.8%).
- Liquidity: about 487.19K shares (≈$1.77M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.63 vs a range of $2.20–$7.95 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 21 open-market buys, 4 sales; latest: Richard Marshak sold 543 shares on May 15, 2026.
- Latest filings: 8-K Sep 22, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 61.57M shares outstanding (Aug 4, 2026), +23.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
TLSI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.90 | 3.90 | 3.58 | 3.63 | 253.52K |
| Oct 15, 2026 | 3.94 | 4.01 | 3.87 | 3.90 | 140.20K |
| Oct 14, 2026 | 3.91 | 4.01 | 3.80 | 3.90 | 192.80K |
| Oct 13, 2026 | 4.12 | 4.12 | 3.94 | 4.00 | 120.10K |
| Oct 12, 2026 | 4.10 | 4.15 | 3.97 | 4.14 | 78.50K |
| Oct 9, 2026 | 4.09 | 4.32 | 3.93 | 4.06 | 198.90K |
| Oct 8, 2026 | 4.20 | 4.20 | 4.02 | 4.13 | 275.50K |
| Oct 7, 2026 | 4.21 | 4.42 | 4.09 | 4.25 | 185.30K |
| Oct 6, 2026 | 4.39 | 4.51 | 4.25 | 4.27 | 153.10K |
| Oct 5, 2026 | 4.30 | 4.40 | 4.20 | 4.38 | 132.70K |
| Oct 2, 2026 | 4.22 | 4.47 | 4.04 | 4.32 | 145.40K |
| Oct 1, 2026 | 4.27 | 4.27 | 4.02 | 4.15 | 273.20K |
| Sep 30, 2026 | 4.26 | 4.50 | 4.24 | 4.31 | 627.00K |
| Sep 29, 2026 | 4.36 | 4.42 | 4.17 | 4.25 | 186.40K |
| Sep 28, 2026 | 4.28 | 4.40 | 4.08 | 4.39 | 253.80K |
| Sep 25, 2026 | 4.57 | 4.62 | 4.32 | 4.34 | 351.20K |
| Sep 24, 2026 | 4.98 | 5.30 | 4.58 | 4.61 | 806.60K |
| Sep 23, 2026 | 5.78 | 5.83 | 4.92 | 5.00 | 2.60M |
| Sep 22, 2026 | 4.98 | 5.15 | 4.82 | 4.93 | 2.61M |
| Sep 21, 2026 | 5.14 | 5.22 | 4.92 | 4.98 | 161.20K |
About TriSalus Life Sciences
TriSalus Life Sciences (TLSI) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in WESTMINSTER, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1826667.
TLSI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gary B. Gordon | Director | May 18, 2026 |
| Kerry R Hicks | Director | May 15, 2026 |
| David J Matlin | Director | May 15, 2026 |
| Michael P Stansky | Director | May 18, 2026 |
| Mary T Szela | CEO and President | Jul 1, 2026 |
| William Valle | Director | May 15, 2026 |
| Mats Wahlstrom | Director | May 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bryan F. Cox | Chief of Research | Mar 20, 2026 |
| Jodi Devlin | Chief of Clinical Operations | Mar 20, 2026 |
| Richard Marshak | Chief Commercial Officer | Jul 1, 2026 |
| Richard Henry Marshall | Chief Medical Officer | Jun 29, 2026 |
| David Patience | Chief Financial Officer | Jul 6, 2026 |
| Jennifer Stevens | Chief Regulatory Officer | Mar 20, 2026 |
| Mary T Szela | CEO and President | Jul 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | Richard Marshak | Sale | 543 | $2.67 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | David Patience | Buy | 7,100 | $2.43 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mats Wahlstrom | Buy | 60,000 | $2.53 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
| May 15, 2026 | Mary T Szela | Buy | 39,682 | $2.59 |
TLSI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $45.15M | $-39.23M | -1.84 | $-18.01M |
| Dec 31, 2024 | $29.43M | $-30.05M | -1.31 | $-40.84M |
| Dec 31, 2023 | $18.51M | $-59.36M | -6.77 | $-50.58M |
| Dec 31, 2022 | $12.40M | $-47.19M | -161.55 | $-32.31M |
| Dec 31, 2021 | — | $4.77M | — | $-1.74M |
Latest balance sheet: total assets $62.45M, total liabilities $55.90M, cash $46.29M (as of Jun 30, 2026).
TLSI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.87 |
| May 12, 2026 | 8-K Item 2.02 (results) | $4.56 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $4.77 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $5.87 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $4.39 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $3.65 |
| May 15, 2025 | 8-K Item 2.02 (results) | $5.11 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $5.13 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $5.50 |
| Feb 3, 2025 | 8-K Item 2.02 (results) | $5.33 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $5.16 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $4.01 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TLSI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.